Hemagglutinin binding mediated protection of botulinum neurotoxin from proteolysis

Journal of Natural Toxins

Volumn 7, Issue 3, 1998, Pages 239-253

  Sharma, Shashi Kant ^a   Singh, Bal Ram ^a  

^a UNIVERSITY OF MASSACHUSETTS DARTMOUTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; CHYMOTRYPSIN; HEMAGGLUTININ; PEPSIN A; PEPTIDE FRAGMENT; SUBTILISIN; TRYPSIN;

AFFINITY CHROMATOGRAPHY; CHEMISTRY; CONFERENCE PAPER; CULTURE MEDIUM; ISOLATION AND PURIFICATION; MOLECULAR WEIGHT; POLYACRYLAMIDE GEL ELECTROPHORESIS;

BOTULINUM TOXIN TYPE A; CHROMATOGRAPHY, AFFINITY; CHYMOTRYPSIN; CULTURE MEDIA; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HEMAGGLUTININS; MOLECULAR WEIGHT; PEPSIN A; PEPTIDE FRAGMENTS; SUBTILISINS; TRYPSIN;

CLOSTRIDIUM BOTULINUM;

EID: 0032189946     PISSN: 10588108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (21)

1. Balding, P., Gold, E. R., Boroff, D. A., and Roberts, T. A. (1973). Hemagglutination and hemagglutination-inhibition reactions of Clostridium botulinum types A, C, D, and E hemagglutinins. Immunology 25, 773-782.
2. Boroff, D. A., Townend, R., Fleck, U., and DasGupta, B. R. (1966). Ultracentrifugation analysis of the crystalline toxin and isolated fraction of clostridium toxin type A. J. Biol. Chem. 241, 5165-5167.
3. East, A. K., and Collins, M. D. (1994). Conserved structure of gene encoding components of botulinum neurotoxin complex M and the sequence of the gene coding for the nontoxic component in nonproteolytic Clostridium botulinum type F. Current Microbiol. 29, 69-77.
4. Fu, Fen-Ni, Sharma, S. K., and Singh, B. R. (1998). Purification, biological activity and molecular properties of novel hemagglutinin from type A Clostricium botulinum. J. Prot. Chem. 17, 53-60.
5. Fujii, N., Kimura, K., Tsuzuki, K., Yokosawa, N., and Oguma, K. (1993). Construction and expression of genes for neurotoxin and nontoxic components of C. botulinum type C and E. In: Botulinum and Tetanus Neurotoxins, B. R. DasGupta (Ed.), pp. 405-120. Plenum Press, New York.
6. Fujinaga, Y., Inoue, K., Watanabe, S., Yokota, K., Hivais, Y., Kozaki, S. Nagamachi, E., and Oguma, K. (1997). In: Second International Meeting of the Molecular Genetics and Pathogenesis of the Clostridia, June 22-25, Seillac, Onzain, France.
7. Hall, J. D., McCrosky, L. M., Pincomb, B. J., and Hathway, C. L. (1985). Isolation of an organism resembling Clostridium barati which produces type F botulinum from an infant with botulinum. J. Clin. Microbiol. 21, 654-655.
8. Hauser, D., Eklund, M. W., Boquet, P., and Popoff, M. R. (1994). Organization of the botulinum neurotoxin C1 gene and its associated nontoxic protein genes in Clostridium botulinum C 468. Mol. Gen. Genet. 243, 631-640.
9. Inoue, K., Fujinaga, Y., Watanabe, T., Ohyama, T., Takeshi, K., Moniishi, K., Nakajima, H., Inoue, K., and Oguma, K. (1996). Molecular composition of Clostridium botulinum type A progenitor toxin. Infect. Immun. 64, 1589-1594.
10. Kitamura, M., and Sakaguchi, G. (1969). Dissociation and reconstitution 12 S toxin of Clostridium botulinum type F. Biochim. Biophys. Acta 194, 892-897.
11. Kitamura, M., Sakaguchi, S., and Sakaguchi, G. (1976). Dissociation of Clostridium botulinum type E toxin. Biochem. Biophys. Res. Commun. 29, 892-897.
12. Lamanna, C. (1948). Hemagglutination by botulinal toxin. Proc. Soc. Exp. Biol. Med. 69, 332-336.
13. Lamanna, C., MacElory, O. E., and Eklund, H. W. (1946). The purification and crystallization of Clostridium botulinum type A toxin. Science 103, 613-614.
14. McCrosky, L. M., Hatheway, C. L., Fenicia, L., Pasolini, B., and Aureli, P. (1986). Characterization of an organism that produces type E botulism toxin but which resembles Clostridium butyricum from the faces of an infant with type E botulism. J. Clin. Microbiol. 23, 201.
15. Nukina, M., Mochida, Y., Miyata, T., Sakaguchi, S., and Sakaguchi, G. (1993). Purification, characterization and oral toxicity of botulinum type G progenitor toxin. In: Botulinum and Tetanus Neurotoxins, B. R. DasGupta (Ed.), pp. 401-404. Plenum Press, New York.
16. Sakaguchi, G. (1983). Clostridium botulinum toxins. Pharmac. Ther. 19, 165-194.
17. Singh, B. R., Foley, J., and Lafontaine, C. (1995a). Physiological characterization of the type E botulinum neurotoxin binding proteins purified from Clostridium botulinum. J. Prot. Chem. 14(1), 7-18.
18. Singh, B. R., Li, B., and Reed, D. (1995b). Botulinum versus tetanus neurotoxins: Why is a botulinum neurotoxin food poison but not tetanus neurotoxin? Toxicon 33, 1541-1547.
19. Somers, E., and DasGupta, B. R. (1991). Clostridium botulinum type A, B, C1, and E produce proteins with or without hemagglutinin activity: Do they share common amino acid sequence and gene? J. Prot. Chem. 10(4), 415-425.
20. Sugii, S., and Sakaguchi, G. (1997). Botulogenic properties of vegetables with special reference to the molecular size of toxin in them. J. Food Safety 1, 53-65.
21. Tsuzuki, K., Kouichi, K., Nobuhiro, F., Noriko, Y., Tomokazu, I., Tadayuki, M., and Keiji, O. (1990). Cloning and complete nucleotide sequence of the gene for the main component of hemagglutinin produced by C. botulinum type C. Infect. Immun. 58, 3173-3177.